Skip to main content
Premium Trial:

Request an Annual Quote

NCI, ESTools License Integromics Software

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Integromics said today that the National Cancer Institute and the ESTools consortium, a European stem cell research organization, have purchased site-wide licenses for its RealTime StatMiner data analysis software solution.

The agreements will enable every researcher based at NCI and ESTools consortium members to use the gene expression software to perform validated bioinformatics analysis of functional gene expression data.

Madrid-based Integromics developed the solution through a partnership with Applied Biosystems.

ESTools Coordinator Peter Andrews said in a statement that the StatMiner software has helped the researchers streamline their data analyses and has given them a way to analyze data from the Applied Biosystems TaqMan Array Cards, and to compare the phenotype of different cell lines against specific standards.

Financial terms of the license agreements were not released.

The Scan

Removal Inquiry

The Wall Street Journal reports that US lawmakers are seeking additional information about the request to remove SARS-CoV-2 sequence data from a database run by the National Institutes of Health.

Likely to End in Spring

Free lateral flow testing for SARS-CoV-2 may end in the UK by next spring, the head of Innova Medical Group says, according to the Financial Times.

Searching for More Codes

NPR reports that the US Department of Justice has accused an insurance and a data mining company of fraud.

Genome Biology Papers on GWAS Fine-Mapping Method, COVID-19 Susceptibility, Rheumatoid Arthritis

In Genome Biology this week: integrative fine-mapping approach, analysis of locus linked to COVID-19 susceptibility and severity, and more.